According to the latest report by IMARC Group, titled, “Acne Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028“, Offers a comprehensive analysis of the industry, which comprises insights on the acne drugs market growth. The global acne drugs market size reached US$ 6.5 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 9.2 Billion by 2028, exhibiting a growth rate (CAGR) of 5.3% during 2023-2028.
Acne drugs are medications that help in reducing acne by treating its causes. They assist in reducing oil production on the skin surface and regulate skin cell turnover. Moreover, they help fight inflammation, reduce bacterial infection, treat existing blemishes, and prevent the occurrence of new acne. At present, they include retinoids, antibiotics, hormonal agents, and combination drugs, which are available in topical, oral, and injectable forms.
Acne Drugs Market Trends and Drivers:
The increasing prevalence of skin diseases represents one of the primary factors positively influencing the market across the globe. In addition, rising global pollution levels are aggravating acne vulgaris and resulting in clogged pores, which make skin age faster. This, in confluence with an unhealthy diet and hormonal changes, is creating a favorable market outlook. Furthermore, the growing awareness about the availability of products containing antibiotic agents, such as creams, gels, and lotions, is bolstering the market growth around the world. Additionally, the growing influence of social media is promoting the usage of acne drugs to achieve the desired appearance, which is strengthening the market growth. Other factors like inflating disposable incomes and the easy availability of acne drugs through both online and offline distribution channels are stimulating the growth of the market worldwide.
Acne Drugs Market Report 2023-2028 Competitive Analysis and Segmentation:
The competitive landscape of the industry has also been examined along with the profiles of the key players.
- Allergan Plc
- Bausch Health Companies Inc.
- Bayer Aktiengesellschaft
- Cipher Pharmaceuticals Inc.
- Galderma Holding SA
- Johnson & Johnson
- Pfizer Inc.
- Reckitt Benckiser Group Plc
- Skinvisible Pharmaceuticals Inc.
- Sun Pharmaceutical Industries Limited
- Teva Pharmaceutical Industries Ltd.
The report has segmented the market based on acne type, drug class, drug type and route of administration.
Breakup by Acne Type:
Breakup by Drug Class:
- Hormonal Agents
- Combination Drugs
Breakup by Drug Type:
- OTC Drugs
- Prescription Drugs
Breakup by Route of Administration:
Breakup by Region:
- North America
- Latin America
- Middle East and Africa
Ask Analyst for 10% Free Customized Report:
Key highlights of the report:
- Market Performance (2017-2022)
- Market Outlook (2023-2028)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Address: 134 N 4th St. Brooklyn, NY 11249, USA
Website: https://www.imarcgroup.com/Follow us on Twitter: @imarcglobal